Literature DB >> 18496936

A randomized trial of unruptured brain arteriovenous malformations (ARUBA).

J P Mohr1.   

Abstract

Despite almost a century of efforts in the treatment of brain arteriovenous malformations (BAVMs) no clinical trial has yet been performed to demonstrate the benefits of intervention versus conservative (medical) management for those not yet bled. Only insufficient information on the natural history of unbled BAVMs exists to certify that intervention is needed and that such intervention produces a better long-term functional outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18496936     DOI: 10.1007/978-3-211-76589-0_1

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  4 in total

Review 1.  Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Authors:  Kellen E Haley; Steven M Greenberg; M Edip Gurol
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 2.  Management of unbled brain arteriovenous malformation study.

Authors:  J P Mohr; Shadi Yaghi
Journal:  Neurol Clin       Date:  2015-05       Impact factor: 3.806

Review 3.  [Intracranial aneurysm, arteriovenous malformation, and carotid artery stenosis : endovascular prophylactic therapy].

Authors:  G Richter; M Köhrmann; S Schwab; A Dörfler
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

4.  Liquid embolization material reduces the delivered radiation dose: clinical myth or reality?

Authors:  F Bing; R Doucet; F Lacroix; J P Bahary; T Darsaut; D Roy; F Guilbert; J Raymond; A Weill
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.